Hum. Reprod. Advance Access published online on October 9, 2008
Human Reproduction, doi:10.1093/humrep/den356
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats
1 Division of High Risk Pregnancy, Mackay Memorial Hospital, 92 Sec. 2 Chung-San North Road, Taipei 104, Taiwan 2 Department of Medical Research, Mackay Memorial Hospital, Taipei 104, Taiwan 3 Mackay Medicine, Nursing and Management College, Taipei 112, Taiwan 4 Maternal and Fetal Health Research Group, University of Manchester, St Marys Hospital, Manchester M13 0JH, UK
5Correspondence address.Tel: +886-2-2543-3535; Fax: +886-2-2754-3769; E-mail: cpchen{at}ms2.mmh.org.tw
BACKGROUND: Human placental mesenchymal stem cells (hPMCs) are thought to be multipotent, but their fate after in utero transplantation is not known.
METHODS: hPMCs isolated from term placenta were assessed for their phenotype markers, mutilineage capacity, and immunomodulatory properties. Their engraftment potential was analyzed in a pregnant rat model after in utero transplantation at embryonic day 17. Immunohistochemistry, tracing of labeled cells, fluorescence in situ hybridization and real-time PCR were used to assess post-transplant chimerism.
RESULTS: In vitro, lineage-negative, CD34-negative hPMCs differentiated into osteocytes, adipocytes, hepatocytes and endothelial cells with tube formation, and actively suppressed the rat lymphocyte proliferative response to allogeneic lymphocyte stimulation (P < 0.0001). After in utero transplantation into pregnant rats, a low level of engraftment was achieved in various fetal tissues. Engraftment occurred in more than 60% of the fetal rats. Cells persisted for at least 12 weeks after delivery and evidence was obtained to suggest differentiation into specific lineages, including hepatocytes and hematopoietic cells. However, a greater number of hPMCs migrated to the placenta than to the fetus, thus limiting the degree of cell engraftment in fetal organs.
CONCLUSIONS: We conclude that hPMCs are mutipotent cells that can be engrafted long-term in immunocompetent rats after in utero transplantation.
Key words: engraftment/in utero transplantation/mesenchymal stem cells/placenta/rat
Submitted on August 14, 2007; resubmitted on August 17, 2008; accepted on August 21, 2008.